Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Future Oncology (London, England)
|
November 8, 2012
Single circulating tumor cell profiling: a new perspective for targeted therapy?
M C Cassatella, L Zorzino, M T Sandri
Biochemistry International
|
October 1, 1990
Subcellular metabolism of exogenous GM1 ganglioside in normal human fibroblasts
A Giglioni, M Pitto, V Chigorno, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 30, 2008
Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncological hospital
R Passerini, D Riggio, D Radice, et al.
The International Journal of Artificial Organs
|
December 1, 1993
Clinical application of growth factors for collection of circulating hematopoietic progenitors in breast cancer patients treated with high-dose cyclophosphamide
F Ravagnani, P Notti, S Siena, et al.
The International Journal of Artificial Organs
|
December 1, 1993
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients
M Di Nicola, S Siena, M Bregni, et al.
Anticancer Research
|
July 11, 2006
Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer
M G Zampino, K Lorizzo, A Rocca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects
M Colleoni, L Orlando, G Sanna, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2008
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?
M G Zampino, E Magni, L Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2007
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
F Nolé, E Munzone, L Zorzino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
M Colleoni, A Rocca, M T Sandri, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Future Oncology (London, England)
|
November 8, 2012
Single circulating tumor cell profiling: a new perspective for targeted therapy?
M C Cassatella, L Zorzino, M T Sandri
Biochemistry International
|
October 1, 1990
Subcellular metabolism of exogenous GM1 ganglioside in normal human fibroblasts
A Giglioni, M Pitto, V Chigorno, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 30, 2008
Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncological hospital
R Passerini, D Riggio, D Radice, et al.
The International Journal of Artificial Organs
|
December 1, 1993
Clinical application of growth factors for collection of circulating hematopoietic progenitors in breast cancer patients treated with high-dose cyclophosphamide
F Ravagnani, P Notti, S Siena, et al.
The International Journal of Artificial Organs
|
December 1, 1993
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients
M Di Nicola, S Siena, M Bregni, et al.
Anticancer Research
|
July 11, 2006
Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer
M G Zampino, K Lorizzo, A Rocca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects
M Colleoni, L Orlando, G Sanna, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2008
Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?
M G Zampino, E Magni, L Santoro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2007
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
F Nolé, E Munzone, L Zorzino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
M Colleoni, A Rocca, M T Sandri, et al.
Page
of 2